The world of Scope 3 emissions: Cut the complexity with creative collaboration
Join Thibault Renaud, Sustainability Supply Chain Leader at Cytiva, and Rachel Delacour, CEO and Cofounder of SWEEP, as they dive into the crucial role of Scope 3 emissions in the biopharma industry's sustainability journey.
In this webinar, we explore the challenges and opportunities of managing Scope 3 emissions, the importance of collaboration, and how data platforms are driving progress. Delacour also offers advice on leveraging technology to improve the accuracy of sustainability data and effectively manage emissions.
Speakers:
Thibault Renaud, Sustainability Strategy and Supply Chain Manager, Cytiva
Thibault Renaud’s motto in life and at work is: “Learn stuff and have fun.” He practices that by collaborating with various internal and external experts, challenging the status quo, and looking for better and new innovative ways of operating.
Renaud joined GE Healthcare in 2014 and has been promoted into different supply chain roles, such as sourcing and logistic strategy, before joining the first sustainability working group at Cytiva in January 2020. In early 2021, Renaud’s responsibilities increased to lead a program identifying and achieving sustainability targets in our packaging, logistics, sourcing, and carbon management. He now leads the sustainability transformation strategy effort across Cytiva.
Rachel Delacour, CEO and Co-Founder, Sweep
Sweep co-founder and CEO Rachel Delacour is an award-winning repeat entrepreneur with a background in finance. In 2009, she cofounded BIME Analytics, a pioneering business intelligence SaaS which was acquired by US customer service company Zendesk six years later. Delacour worked there as general manager until she decided to use her talent to help clean the climate mess with Sweep.
A leading female figure in European tech, Delacour was elected co-president of France Digitale in 2018 and her thought leadership has been featured in The Economist and The Wall Street Journal. An advocate for women in tech, she has backed several female-founded US and French startups.
We surveyed 800 biopharma professionals from 18 different countries to assess the progress the industry has made relating to sustainability. Dive into our full Biopharma Sustainability Review for more insights. Visit: https://cytiva.link/jpntx